Patients don't regain much weight switching from injections to Lilly's weight-loss pill, study finds

By Chris Prentice NEW YORK, May 12 (Reuters) - Eli Lilly said on Tuesday that patients in a late-stage trial who had been ...

Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight

Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity ...
FiercePharma

The Oral GLP-1 Tracker: Wegovy pill total scripts down for first time

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
BioPharma Dive

Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss

A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down over the long term.